Key statistics
As of last trade, Shield Therapeutics PLC (STX:LSE) traded at 2.70, 154.12% above the 52 week low of 1.06 set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.75 |
---|---|
High | 2.70 |
Low | 2.69 |
Bid | 2.65 |
Offer | 2.70 |
Previous close | 2.75 |
Average volume | 1.71m |
---|---|
Shares outstanding | 782.06m |
Free float | 295.94m |
P/E (TTM) | -- |
Market cap | 21.51m GBP |
EPS (TTM) | -0.0477 GBP |
Data delayed at least 20 minutes, as of Nov 11 2024 09:44 GMT.
More ▼
- Q3 Trading Update
- Results from Phase 3 paediatric study
- Interim results
- ACCRUFeR® Approved by Health Canada
- Notice of interim results
- Unaudited Q2 2024 Trading Update
- Directorate Change
- $5.7m Milestone Monetization Agreement with AOP
- Results of 2024 Annual General Meeting
- New Drug Application for Accrufer® in South Korea
More ▼